Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

(2018) L Clifford McDonald et al.   CLINICAL INFECTIOUS DISEASES

Uso de un sistema de puntuación para la prescripción de fidaxomicina en la infección por Clostridium difficile

(2018) María Jesús Vivancos-Gallego et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Cwp19 Is a Novel Lytic Transglycosylase Involved in Stationary-Phase Autolysis Resulting in Toxin Release in Clostridium difficile

(2018) Sandra Wydau-Dematteis et al.   mBio

The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection

(2018) Ravi K. R. Marreddy et al.   ACS Infectious Diseases

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus

(2016) Qiwen Hu et al.   Frontiers in Microbiology

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014

(2016) Lindsey M. Weiner et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

A multi-center study of fidaxomicin use for Clostridium difficile infection

(2016) Dhara N. Shah et al.   SpringerPlus

A Phenotypically Silent vanB2 Operon Carried on a Tn 1549 -Like Element in Clostridium difficile

(2016) Daniel R. Knight et al.   mSphere

Structural basis of DNA sequence recognition by the response regulator PhoP in Mycobacterium tuberculosis

(2016) Xiaoyuan He et al.   Scientific Reports

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

(2015) D. R. Snydman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes

(2015) J. Freeman et al.   CLINICAL MICROBIOLOGY AND INFECTION

A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole

(2015) Amos Adler et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection

(2015) Abrar K. Thabit et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening

(2015) Vicenta Cázares-Domínguez et al.   PLoS One

Discovery of Novel Cell Wall-Active Compounds Using PywaC, a Sensitive Reporter of Cell Wall Stress, in the Model Gram-Positive Bacterium Bacillus subtilis

(2014) T. L. Czarny et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Strain Types and Antimicrobial Resistance Patterns of Clostridium difficile Isolates from the United States, 2011 to 2013

(2014) Isabella A. Tickler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

(2014) Stuart Johnson et al.   CLINICAL INFECTIOUS DISEASES

In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin

(2013) J. A. Leeds et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The functionalvanGCdcluster ofClostridium difficiledoes not confer vancomycin resistance

(2013) Fariza Ammam et al.   MOLECULAR MICROBIOLOGY

Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan

(2012) Chun-Hsing Liao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates

(2012) Fariza Ammam et al.   CANADIAN JOURNAL OF MICROBIOLOGY

The Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999–2007

(2012) Aron J. Hall et al.   CLINICAL INFECTIOUS DISEASES

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

(2011) Milagros Gonzales et al.   BMC INFECTIOUS DISEASES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY